Navigation Links
CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
Date:10/27/2010

WOBURN, Mass., Oct. 27 /PRNewswire/ -- CutisPharma, Inc. today announced that it has received approval from the United States Patent and Trademark Office for its patent (US 7,815,929) regarding a method for the preparation, storage and dispensing of compounded suppositories.

"By its very nature, the process of compounding suppositories is cumbersome, time-consuming and in general, without adequate compensation," said Dr. Indu Muni, founder, chairman, and CEO of CutisPharma, Inc. "Our container (suppository mold) and the method for suppository-compounding is user-friendly and time saving for a pharmacy. Our suppository mold is also customer friendly because the take-home molds are especially designed to not only maintain the integrity of each suppository once compounded, but also provide convenient patient dispensing," he added.

The patented container is currently used in CutisPharma's FIRST® Progesterone Vaginal Suppository Unit-of-Use Prescription Compounding Kit product line which includes FIRST® - Progesterone VGS 25, 50, 100, 200 and 400 representing various strengths (mg.).  The kits are made for a single patient and include pre-weighed progesterone, and suppository base, and a disposable container/mold for preparation, storage, and dispensing of the suppositories. A single NDC number assigned for the entire kit aids the third party reimbursement process, reduces audit- related adjustments, and the use of these FIRST® kits facilitates compliance with USP Chapter <795>.

CutisPharma estimates that over 1.5 million progesterone suppository prescriptions are written in the U.S. annually, representing a potential of nearly $100 million at the retail level. The Kit allows a pharmacy an easy entry into this market.  The Company is experiencing a steady conversion from the conventional way to the FIRST® - way.

FIRST® products save dispensing time, are easy to use, and can be compounded by the phar
'/>"/>

SOURCE CutisPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction
2. Anthera Announces Third Quarter 2010 Financial Report and Conference Call
3. Onyx Pharmaceuticals Announces Third Quarter 2010 Financial Results Teleconference and Webcast
4. Baxa Corporation Announces 2011 Course Schedule for its STAR Center® Training Facility
5. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
6. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
7. Stereotaxis Announces Third Quarter 2010 Earnings Release Date and Conference Call
8. Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010
9. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
10. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
11. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... NEW YORK , Dec. 17, 2014 /PRNewswire-USNewswire/ ... resonance imaging (MRI), the MRI market is seeing ... cardiovascular and breast MRI scans account for the ... providing a higher resolution of images, which are creating ... resonance imaging (MRI) market is growing at a ...
(Date:12/17/2014)... -- , The new Dompé ... information concerning the biopharmaceutical Group,s national and international clinical research ... the recently launched institutional website that is receiving accolades from ... a new chapter in the fascinating story of Drug Discovery ... panoramic hub on the world of clinical research, ranging from ...
(Date:12/17/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or ... of $125 million aggregate principal amount of 3.75% Convertible ... offered and sold only to qualified institutional buyers pursuant ... as amended (the "Securities Act"). The Notes ... year, payable semiannually in arrears on June 15 and ...
Breaking Medicine Technology:Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4
... Oct. 25 In 73 years, Dr. Katherine Jeter has ... required an ostomy, she not only provided specialized care, she ... battling a personal health crisis, she recovered and focused on ... to increase the number of nurses trained to meet the ...
... the Pennsylvania State Police are reminding motorists that driving ... can be just as dangerous as driving under the ... PennDOT will work with state and municipal police departments ... increased emphasis on driving under the influence of drugs ...
Cached Medicine Technology:73-Year-Old Educator Embarks on Personal Challenge to Cycle 3,100 Miles to Raise $200,000 for WOC Nursing Scholarships 2PennDOT, State Police Caution Motorists About Dangers of Driving Under Influence of Legal Drugs 2
(Date:12/17/2014)... participation in music classes may benefit children,s language development, ... the nonprofit Harmony Project, which provides music education and ... two years, children who actively participated in the classes ... and reading, compared to those with lower levels of ... music classes occurred in the same areas of the ...
(Date:12/17/2014)... Kathleen Doheny HealthDay ... Chronic sleep loss is rampant in America, and work commitment ... is the No. 1 sleep killer," said Dr. Mathias Basner, ... the University of Pennsylvania Perelman School of Medicine. A ... older, found that work is the main activity exchanged for ...
(Date:12/15/2014)... Veretekk.com, Inc. announced today a strategic alliance ... Ocean Avenue has secured exclusive benefit to the strategic ... JM Ocean Avenue is a direct sales company ... and JM International, with partial ownership coming from JM ... , “After nearly 2 decades of servicing the industry ...
(Date:12/15/2014)... SIMpalm, a leading mobile app ... iPhone for its client, which allows users to keep ... specialized in finding the right wine. At the ... combined sensory, chemistry and wine information. All this information ... fingerprint.” Those wines that are close counterparts to one ...
(Date:12/15/2014)... HealthDay Reporter FRIDAY, Dec. 12, ... the millions of American women who have migraine: The debilitating ... is no association between migraine and breast cancer risk," said ... Harvard Medical School. "There is no positive association, so there ... effect either." About 18 percent of American women and ...
Breaking Medicine News(10 mins):Health News:Music Classes Boost Language Skills, Study Says 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... , WEDNESDAY, Jan. 26 (HealthDay News) -- As long as ... opponents convinced that these shots do more harm than good. ... expressed more vehemently than with the standard measles-mumps-rubella (MMR) childhood ... after the retraction last year by The Lancet ...
... -- Scientists have pinpointed two gene variants that protect hepatitis ... findings are detailed in two studies that appear online and ... . The ability to identify patients with the two ... that antiviral therapy is completed and the hepatitis C virus ...
... , WEDNESDAY, Jan. 26 (HealthDay News) -- Arizona Congresswoman ... Houston Wednesday morning after her doctors upgraded her condition ... her remarkable recovery from a gunshot wound to the ... Center determined that she could be moved to nearby ...
... Vascular and Interventional Radiology the monthly, peer-reviewed flagship ... major changes for 2011all directed at highlighting the ... and its lead journal. JVIR, which has been ... medical, minimally invasive, radiological, pathological and socioeconomic issues ...
... new target for the prevention of adverse immune responses identified ... been discovered by researchers at the University of South Florida,s ... and Brain Repair. Their findings are published online in ... The CD45 molecule is a receptor on the surface of ...
... its kind surgical quality improvement program for children has the ... be targeted for quality improvement efforts to prevent complications and ... College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS NSQIP ... of the Journal of the American College of Surgeons ...
Cached Medicine News:Health News:Fear of Vaccines Has a Long, Persistent History 2Health News:Fear of Vaccines Has a Long, Persistent History 3Health News:Fear of Vaccines Has a Long, Persistent History 4Health News:Rep. Giffords Moved to Rehab Facility 2Health News:Rep. Giffords Moved to Rehab Facility 3Health News:Journal of Vascular and Interventional Radiology debuts new look, reflects global impact 2Health News:Journal of Vascular and Interventional Radiology debuts new look, reflects global impact 3Health News:Stimulating the brain's immune response may provide treatment for Alzheimer's disease 2Health News:First pediatric surgical quality program shows potential to measure children's outcomes 2
Unipolar Atrial "J" Lead...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
Medicine Products: